1
|
Gautam RK, Gupta G, Sharma S, Hatware K, Patil K, Sharma K, Goyal S, Chellappan DK, Dua K. Rosmarinic acid attenuates inflammation in experimentally induced arthritis in Wistar rats, using Freund's complete adjuvant. Int J Rheum Dis 2019; 22:1247-1254. [PMID: 31155849 DOI: 10.1111/1756-185x.13602] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Revised: 04/09/2019] [Accepted: 04/21/2019] [Indexed: 12/23/2022]
Abstract
AIM The purpose of our investigation is to evaluate the anti-arthritic potential of isolated rosmarinic acid from the rind of Punica granatum. METHOD Rosmarinic acid was isolated by bioactivity-guided isolation from butanolic fraction of Punica granatum and acute toxicity of rosmarinic acid was carried out. The experiment was conducted at doses of 25 and 50 mg/kg, in Freund's complete adjuvant (FCA)-induced arthritic rats. Various parameters, that is arthritic score, paw volume, thickness of paw, hematological, antioxidant and inflammatory parameters such as glutathione (GSH), superoxide dismutase (SOD), malonaldehyde (MDA) and tumor necrosis factor-α (TNF-α) were also estimated. RESULTS Rosmarinic acid significantly decreased the arthritic score, paw volume, joint diameter, white blood cell count and erythrocyte sedimentation rate. It also significantly increased body weight, hemoglobin and red blood cells. The significantly decreased levels of TNF-α were observed in treated groups as compared to arthritic control rats (P < 0.001). At the same time antioxidant parameters (like GSH and SOD) were increased significantly while levels of MDA were significantly decreased (P < 0.001). CONCLUSION The outcome of the present research concludes that rosmarinic acid showed significant anti-arthritic potential in FCA-induced arthritis in Wistar rats. This study represented the therapeutic role of rosmarinic acid from Punica granatum for the management of arthritis/rheumatoid arthritis/osteoarthritis and related inflammatory complications with negligible side effects which was still far from complete mitigation with available conventional medicines.
Collapse
Affiliation(s)
- Rupesh Kumar Gautam
- Department of Pharmacology, MM School of Pharmacy, Maharishi Markandeshwar University, Sadopur-Ambala, India
| | - Gaurav Gupta
- School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India
| | - Sanjay Sharma
- NMIMS, School of Pharmacy & Technology Management, Shirpur, India
| | - Ketan Hatware
- NMIMS, School of Pharmacy & Technology Management, Shirpur, India
| | - Kiran Patil
- NMIMS, School of Pharmacy & Technology Management, Shirpur, India
| | - Komal Sharma
- Department of Pharmacology, Bhupal Nobles' Institute of Pharmaceutical Sciences, Udaipur, India
| | - Swapnil Goyal
- Department of Pharmacology, Mandsaur Institute of Pharmacy, Mandsaur, India
| | - Dinesh Kumar Chellappan
- Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Malaysia
| | - Kamal Dua
- Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, NSW, Australia
- Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia
| |
Collapse
|
2
|
Matsuura T, Kawasaki M, Hashimoto H, Ishikura T, Yoshimura M, Ohkubo JI, Maruyama T, Motojima Y, Sabanai K, Mori T, Ohnishi H, Sakai A, Ueta Y. Fluorescent Visualisation of Oxytocin in the Hypothalamo-neurohypophysial/-spinal Pathways After Chronic Inflammation in Oxytocin-Monomeric Red Fluorescent Protein 1 Transgenic Rats. J Neuroendocrinol 2015; 27:636-46. [PMID: 25943916 DOI: 10.1111/jne.12290] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Revised: 04/29/2015] [Accepted: 04/29/2015] [Indexed: 11/26/2022]
Abstract
Oxytocin (OXT) is a well-known neurohypophysial hormone that is synthesised in the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus. The projection of magnocellular neurosecretory cells, which synthesise OXT and arginine vasopressin in the PVN and SON, to the posterior pituitary plays an essential role in mammalian labour and lactation through its peripheral action. However, previous studies have shown that parvocellular OXTergic cells in the PVN, which project to the medulla and spinal cord, are involved in various physiological functions (e.g. sensory modulation and autonomic). In the present study, we examined OXT expression in the PVN, SON and spinal cord after chronic inflammation from adjuvant arthritis (AA). We used transgenic rats that express OXT and the monomeric red fluorescent protein 1 (mRFP1) fusion gene to visualise both the magnocellular and parvocellular OXTergic pathways. OXT-mRFP1 fluorescence intensity was significantly increased in the PVN, SON, dorsal horn of the spinal cord and posterior pituitary in AA rats. The levels of OXT-mRFP1 mRNA were significantly increased in the PVN and SON of AA rats. These results suggested that OXT was up-regulated in both hypothalamic magnocellular neurosecretory cells and parvocellular cells by chronic inflammation, and also that OXT in the PVN-spinal pathway may be involved in sensory modulation. OXT-mRFP1 transgenic rats are a very useful model for visualising the OXTergic pathways from vesicles in a single cell to terminals in in vitro preparations.
Collapse
Affiliation(s)
- T Matsuura
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - M Kawasaki
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - H Hashimoto
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Ishikura
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - M Yoshimura
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - J-I Ohkubo
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Maruyama
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Y Motojima
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - K Sabanai
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - T Mori
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - H Ohnishi
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - A Sakai
- Department of Orthopaedics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Y Ueta
- Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| |
Collapse
|